Supplementation with Enterococcus hirae and Barnesiella intestinihominis induces the generation of Th1, Th17, and tumor-specific CD4+ and CD8+ T cells, thereby restoring the antitumor effects of cyclophosphamide (Daillère et al., 2016). The gene discussed is CD4; the disease is neoplasm.